| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $51.0M | +31.0% |
| SG&A Expense | $20.2M | +28.2% |
| Operating Income | -$71.2M | -30.2% |
| Interest Expense | $1.2M | +645.3% |
| Income Tax | $0 | — |
| Net Income | -$68.2M | -24.9% |
| EPS (Basic) | -$1.01 | +2.9% |
| EPS (Diluted) | -$1.01 | +2.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.5M | -35.7% |
| Short-term Investments | $236.1M | +62.3% |
| Current Assets | $285.7M | +35.0% |
| Total Assets | $299.6M | +37.5% |
| Current Liabilities | $11.0M | +33.9% |
| Long-term Debt | $10.0M | +0.0% |
| Total Liabilities | $29.7M | +41.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.8M | -38.7% |
| Capital Expenditures | $1.6M | +399.4% |
| Investing Cash Flow | -$91.4M | -221.3% |
| Financing Cash Flow | $127.9M | +13.6% |
| Free Cash Flow | -$60.4M | -41.3% |
| Stockholders' Equity |
| $269.9M |
| +37.1% |